Advertisement
CDXS 外汇新闻
Codexis Inks Purchase Deal With Nestle Health Science For CDX-7108
Enzyme engineering company Codexis, Inc. (CDXS) announced Wednesday it has entered into a purchase agreement with Nestle Health Science for CDX-7108, an investigational therapy for the potential treatment of exocrine pancreatic insufficiency (EPI).
RTTNews
|
501天前
